HK1000114A1 - Treatment of periodontal disease with alendronate - Google Patents

Treatment of periodontal disease with alendronate Download PDF

Info

Publication number
HK1000114A1
HK1000114A1 HK97101629D HK97101629D HK1000114A1 HK 1000114 A1 HK1000114 A1 HK 1000114A1 HK 97101629 D HK97101629 D HK 97101629D HK 97101629 D HK97101629 D HK 97101629D HK 1000114 A1 HK1000114 A1 HK 1000114A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutically acceptable
treatment
alendronate
periodontal disease
medicament
Prior art date
Application number
HK97101629D
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Inventor
J. Gertz Barry
A. Rodan Gideon
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of HK1000114A1 publication Critical patent/HK1000114A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK97101629D 1991-12-17 1997-08-04 Treatment of periodontal disease with alendronate HK1000114A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/808,701 US5270365A (en) 1991-12-17 1991-12-17 Prevention and treatment of periodontal disease with alendronate

Publications (1)

Publication Number Publication Date
HK1000114A1 true HK1000114A1 (en) 1997-12-05

Family

ID=25199466

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97101629D HK1000114A1 (en) 1991-12-17 1997-08-04 Treatment of periodontal disease with alendronate

Country Status (22)

Country Link
US (1) US5270365A (cs)
EP (1) EP0617624B1 (cs)
JP (1) JP2825654B2 (cs)
KR (1) KR100258667B1 (cs)
AT (1) ATE150646T1 (cs)
AU (1) AU675417B2 (cs)
CA (1) CA2122498A1 (cs)
CY (1) CY2054B1 (cs)
CZ (1) CZ282902B6 (cs)
DE (1) DE69218624T2 (cs)
DK (1) DK0617624T3 (cs)
ES (1) ES2100519T3 (cs)
GR (1) GR3022951T3 (cs)
HK (1) HK1000114A1 (cs)
HU (1) HU221807B1 (cs)
IL (1) IL104109A (cs)
LV (1) LV12084B (cs)
NO (1) NO306197B1 (cs)
NZ (1) NZ246274A (cs)
SK (1) SK280628B6 (cs)
WO (1) WO1993011774A1 (cs)
ZA (1) ZA929712B (cs)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW237386B (cs) * 1992-04-15 1995-01-01 Ciba Geigy
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
WO1995028145A1 (en) * 1994-04-18 1995-10-26 The Procter & Gamble Company Iontophoretic delivery of bisphosphonates to the alveolar bone
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
US6008206A (en) * 1994-09-21 1999-12-28 Merck & Co., Inc. Sodium alendronate preparation for local administration
AU690431B2 (en) * 1995-02-17 1998-04-23 Merck & Co., Inc. Method of lessening the risk of non-vertebral bone fractures
EP0824341A4 (en) * 1995-05-12 1999-07-07 Merck & Co Inc PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
ES2197329T3 (es) * 1996-02-14 2004-01-01 Itzhak Binderman Bisfosfonatos topicos para la prevencion de la reabsorcion osea.
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
ES2210529T3 (es) * 1996-05-17 2004-07-01 MERCK & CO., INC. Formulacion de bisfosfonato efervescente.
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
CN1238691A (zh) * 1996-10-04 1999-12-15 麦克公司 液体阿仑膦酸盐制剂
US5773429A (en) * 1996-12-11 1998-06-30 Fuisz Technologies Ltd. Drug combination for treating calcium loss
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
KR20030097611A (ko) * 1997-07-22 2003-12-31 머크 앤드 캄파니 인코포레이티드 골 흡수 억제를 위한 조성물
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
US6331533B1 (en) 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
PL349438A1 (en) * 1998-12-23 2002-07-29 Jomaa Pharmaka Gmbh Use of bisphosphonates for the prevention and treatment of infectious processes
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
US20030216358A1 (en) * 2001-07-05 2003-11-20 Muchmore Douglas Boyer Method for enhancing bone mineral density gain
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
US7960054B2 (en) * 2002-01-10 2011-06-14 Excellatron Solid State Llc Packaged thin film batteries
US20070094865A1 (en) * 2002-01-10 2007-05-03 Ji-Guang Zhang Packaged thin film batteries and methods of packaging thin film batteries
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
WO2003086415A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
FR2838339B1 (fr) * 2002-04-12 2005-06-24 Univ Angers Derives poly-phosphonates pour compositions dentifrices
US20040137058A1 (en) * 2002-07-09 2004-07-15 Katdare Ashok V. Effervescent bisphosphonate formulation
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US20060034921A1 (en) * 2004-01-05 2006-02-16 Katdare Ashok V Effervescent bisphosphonate formulation
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US7731765B2 (en) 2004-02-20 2010-06-08 Excellatron Solid State, Llc Air battery and manufacturing method
US20080070087A1 (en) * 2004-02-20 2008-03-20 Excellatron Solid State, Llc Non-volatile cathodes for lithium oxygen batteries and method of producing same
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
KR100564628B1 (ko) * 2004-06-16 2006-03-28 삼성전자주식회사 스플릿 게이트형 플래쉬 메모리 소자 및 그 제조방법
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
KR20080087782A (ko) * 2005-10-11 2008-10-01 엑셀라트론 솔리드 스테이트 엘엘씨 리튬 배터리 제조 방법
US20070087052A1 (en) * 2005-10-19 2007-04-19 Katdare Ashok V Effervescent bisphosphonate formulation
US20090118238A1 (en) * 2007-09-17 2009-05-07 Protia, Llc Deuterium-enriched alendronate
WO2011017253A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
RU2449761C1 (ru) * 2011-03-09 2012-05-10 Светлана Минифаритовна Алетдинова Способ лечения хронических апикальных периодонтитов
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US9579360B2 (en) 2012-06-20 2017-02-28 The Trustees Of The University Of Pennsylvania Methods of treating or preventing periodontitis and diseases associated with periodontitis
RU2713257C1 (ru) * 2019-05-06 2020-02-04 Жанна Владимировна Вечеркина Способ лечения хронического апикального периодонтита

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429963A (en) * 1964-06-09 1969-02-25 Colgate Palmolive Co Dental preparation containing polymeric polyelectrolyte
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4440779A (en) * 1981-06-30 1984-04-03 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
ATE64397T1 (de) * 1986-11-21 1991-06-15 Ciba Geigy Ag Aromatisch substituierte azacycloalkylalkandiphosphons|uren.
EP0274346B1 (de) * 1986-11-21 1991-03-06 Ciba-Geigy Ag Neue Substituiertaminomethandiphosphonsäuren
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
US4816437A (en) * 1987-06-01 1989-03-28 Trustees Of Boston University Methods for inducing general and localized bone apposition in-vivo
EP0317505A1 (de) * 1987-11-13 1989-05-24 Ciba-Geigy Ag Neue Azacycloalkylalkandiphosphonsäuren
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
EP0320455B1 (de) * 1987-12-11 1993-06-09 Ciba-Geigy Ag Araliphatylaminoalkandiphosphonsäuren
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
GB9008433D0 (en) * 1990-04-12 1990-06-13 Beecham Group Plc Novel compositions
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof

Also Published As

Publication number Publication date
IL104109A (en) 1997-02-18
SK72794A3 (en) 1995-04-12
IL104109A0 (en) 1993-05-13
CY2054B1 (en) 1998-04-30
LV12084B (en) 1998-11-20
US5270365A (en) 1993-12-14
AU675417B2 (en) 1997-02-06
NO306197B1 (no) 1999-10-04
KR940703676A (ko) 1994-12-12
JPH07502506A (ja) 1995-03-16
CZ282902B6 (cs) 1997-11-12
LV12084A (lv) 1998-07-20
NO942267L (no) 1994-06-16
AU3242093A (en) 1993-07-19
HU221807B1 (hu) 2003-01-28
KR100258667B1 (ko) 2000-07-01
WO1993011774A1 (en) 1993-06-24
ZA929712B (en) 1993-06-14
EP0617624B1 (en) 1997-03-26
JP2825654B2 (ja) 1998-11-18
CA2122498A1 (en) 1993-06-24
EP0617624A1 (en) 1994-10-05
DE69218624D1 (de) 1997-04-30
SK280628B6 (sk) 2000-05-16
HUT68788A (en) 1995-07-28
NZ246274A (en) 1997-02-24
DK0617624T3 (da) 1997-04-21
DE69218624T2 (de) 1997-08-07
ES2100519T3 (es) 1997-06-16
ATE150646T1 (de) 1997-04-15
HU9401378D0 (en) 1994-08-29
GR3022951T3 (en) 1997-06-30
NO942267D0 (no) 1994-06-16
CZ148794A3 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
EP0617624B1 (en) Treatment of periodontal disease with alendronate
Chumbley et al. The effect of indomethacin (an aspirin-like drug) on the rate of orthodontic tooth movement
Loos et al. An evaluation of basic periodontal therapy using sonic and ultrasonic sealers
AU4541496A (en) Inhibition of the degradation of connective tissue matrix protein components in mammals
EP0486561B1 (en) Buccal composition containing s(+) flurbiprofen or ketoprofen
Toth et al. Dental oncology: the management of disease and treatment-related oral/dental complications associated with chemotherapy
US11878031B2 (en) Silicic acids for use in the treatment of periodontitis
Asgary et al. Management of an infected immature tooth with a talon cusp using regenerative endodontic treatment: a case report
CN110678179B (zh) 骨再生剂
HK1000114B (en) Treatment of periodontal disease with alendronate
Jaffin et al. Treatment of juvenile periodontitis patients by control of infection and inflammation: Four case reports
US6682718B1 (en) Remedies for periodontosis
WO2001005403A1 (fr) Medicaments pour soigner les parodontopathies
Abdel-Kader Clinical crown length and reduction in overjet, overbite, and dental height with orthodontic treatment
RU2814391C1 (ru) Способ профилактики кариеса зубов при односеансовой санации полости рта у детей
JP2018090540A (ja) 歯槽骨吸収抑制剤
Hlava et al. Etidocaine HCl local anesthetic for periodontal flap surgery
Aboelnagga et al. Radiographic and clinical assessments of platform switching implant assisted mandibular overdenture in controlled diabetic patients
Parkins Pedodontics: A perspective on prevention
EA046983B1 (ru) Кремниевая кислота для применения в лечении периодонтита

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051208